Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004114486> ?p ?o ?g. }
- W2004114486 endingPage "75" @default.
- W2004114486 startingPage "68" @default.
- W2004114486 abstract "Left ventricular enlargement after myocardial infarction increases the likelihood of an adverse outcome. In an echocardiographic substudy of the Survival and Ventricular Enlargement (SAVE) Trial, we assessed whether captopril would attenuate progressive left ventricular enlargement in patients with left ventricular dysfunction after acute myocardial infarction and, if so, whether this would be associated with improved clinical outcome.Two-dimensional transthoracic echocardiograms were obtained in 512 patients at a mean of 11.1 +/- 3.2 days after infarction and were repeated at 1 year in 420 survivors. Left ventricular size was assessed as left ventricular cavity areas at end diastole and end systole and left ventricular function as percent change in cavity area from end diastole to end systole. Patients were randomly assigned to placebo or captopril, and the incidence of adverse cardiovascular events consisting of cardiovascular death, heart failure requiring either hospitalization or open-label angiotensin-converting enzyme inhibitor therapy, and recurrent infarction were determined over a follow-up period averaging 3.0 +/- 0.6 years. Irrespective of treatment assignment, baseline left ventricular systolic area and percent change in area were strong predictors of cardiovascular mortality and adverse cardiovascular events. At 1 year, left ventricular end-diastolic and end-systolic areas were larger in the placebo than in the captopril group (P = .038, P = .015, respectively), and percent change in cavity area was greater in the captopril group (P = .005). One hundred eleven of the 420 1-year survivors with 1-year echo measurements (26.4%) experienced a major adverse cardiovascular event, and these patients had more than a threefold greater increase in left ventricular cavity areas than those with an uncomplicated course. Sixty-nine patients with adverse cardiovascular events were in the placebo group compared with 42 patients in the captopril-treated group (a risk reduction of 35%, P = .010).Two-dimensional echocardiography provides important and independent prognostic information in patients after infarction. Left ventricular enlargement and function after infarction are associated with the development of adverse cardiac events. Attenuation of ventricular enlargement with captopril in these patients was associated with a reduction in adverse events. This study demonstrates the linkage between attenuation of left ventricular enlargement by captopril after infarction and improved clinical outcome." @default.
- W2004114486 created "2016-06-24" @default.
- W2004114486 creator A5001298251 @default.
- W2004114486 creator A5009342484 @default.
- W2004114486 creator A5031560506 @default.
- W2004114486 creator A5033665054 @default.
- W2004114486 creator A5039145780 @default.
- W2004114486 creator A5039202985 @default.
- W2004114486 creator A5041233721 @default.
- W2004114486 creator A5045775390 @default.
- W2004114486 creator A5054349218 @default.
- W2004114486 creator A5078790133 @default.
- W2004114486 date "1994-01-01" @default.
- W2004114486 modified "2023-10-18" @default.
- W2004114486 title "Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril." @default.
- W2004114486 doi "https://doi.org/10.1161/01.cir.89.1.68" @default.
- W2004114486 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8281697" @default.
- W2004114486 hasPublicationYear "1994" @default.
- W2004114486 type Work @default.
- W2004114486 sameAs 2004114486 @default.
- W2004114486 citedByCount "714" @default.
- W2004114486 countsByYear W20041144862012 @default.
- W2004114486 countsByYear W20041144862013 @default.
- W2004114486 countsByYear W20041144862014 @default.
- W2004114486 countsByYear W20041144862015 @default.
- W2004114486 countsByYear W20041144862016 @default.
- W2004114486 countsByYear W20041144862017 @default.
- W2004114486 countsByYear W20041144862018 @default.
- W2004114486 countsByYear W20041144862019 @default.
- W2004114486 countsByYear W20041144862020 @default.
- W2004114486 countsByYear W20041144862021 @default.
- W2004114486 countsByYear W20041144862022 @default.
- W2004114486 countsByYear W20041144862023 @default.
- W2004114486 crossrefType "journal-article" @default.
- W2004114486 hasAuthorship W2004114486A5001298251 @default.
- W2004114486 hasAuthorship W2004114486A5009342484 @default.
- W2004114486 hasAuthorship W2004114486A5031560506 @default.
- W2004114486 hasAuthorship W2004114486A5033665054 @default.
- W2004114486 hasAuthorship W2004114486A5039145780 @default.
- W2004114486 hasAuthorship W2004114486A5039202985 @default.
- W2004114486 hasAuthorship W2004114486A5041233721 @default.
- W2004114486 hasAuthorship W2004114486A5045775390 @default.
- W2004114486 hasAuthorship W2004114486A5054349218 @default.
- W2004114486 hasAuthorship W2004114486A5078790133 @default.
- W2004114486 hasBestOaLocation W20041144861 @default.
- W2004114486 hasConcept C126322002 @default.
- W2004114486 hasConcept C142724271 @default.
- W2004114486 hasConcept C164705383 @default.
- W2004114486 hasConcept C169554166 @default.
- W2004114486 hasConcept C197934379 @default.
- W2004114486 hasConcept C204787440 @default.
- W2004114486 hasConcept C27016395 @default.
- W2004114486 hasConcept C27081682 @default.
- W2004114486 hasConcept C2777798775 @default.
- W2004114486 hasConcept C2778198053 @default.
- W2004114486 hasConcept C2779479957 @default.
- W2004114486 hasConcept C2779537366 @default.
- W2004114486 hasConcept C2779611605 @default.
- W2004114486 hasConcept C500558357 @default.
- W2004114486 hasConcept C57900726 @default.
- W2004114486 hasConcept C71924100 @default.
- W2004114486 hasConcept C84393581 @default.
- W2004114486 hasConceptScore W2004114486C126322002 @default.
- W2004114486 hasConceptScore W2004114486C142724271 @default.
- W2004114486 hasConceptScore W2004114486C164705383 @default.
- W2004114486 hasConceptScore W2004114486C169554166 @default.
- W2004114486 hasConceptScore W2004114486C197934379 @default.
- W2004114486 hasConceptScore W2004114486C204787440 @default.
- W2004114486 hasConceptScore W2004114486C27016395 @default.
- W2004114486 hasConceptScore W2004114486C27081682 @default.
- W2004114486 hasConceptScore W2004114486C2777798775 @default.
- W2004114486 hasConceptScore W2004114486C2778198053 @default.
- W2004114486 hasConceptScore W2004114486C2779479957 @default.
- W2004114486 hasConceptScore W2004114486C2779537366 @default.
- W2004114486 hasConceptScore W2004114486C2779611605 @default.
- W2004114486 hasConceptScore W2004114486C500558357 @default.
- W2004114486 hasConceptScore W2004114486C57900726 @default.
- W2004114486 hasConceptScore W2004114486C71924100 @default.
- W2004114486 hasConceptScore W2004114486C84393581 @default.
- W2004114486 hasIssue "1" @default.
- W2004114486 hasLocation W20041144861 @default.
- W2004114486 hasLocation W20041144862 @default.
- W2004114486 hasOpenAccess W2004114486 @default.
- W2004114486 hasPrimaryLocation W20041144861 @default.
- W2004114486 hasRelatedWork W1753044666 @default.
- W2004114486 hasRelatedWork W1994918206 @default.
- W2004114486 hasRelatedWork W2062844910 @default.
- W2004114486 hasRelatedWork W2072569427 @default.
- W2004114486 hasRelatedWork W2292029659 @default.
- W2004114486 hasRelatedWork W2370319703 @default.
- W2004114486 hasRelatedWork W2370778587 @default.
- W2004114486 hasRelatedWork W2392044870 @default.
- W2004114486 hasRelatedWork W2413002684 @default.
- W2004114486 hasRelatedWork W3029237815 @default.
- W2004114486 hasVolume "89" @default.
- W2004114486 isParatext "false" @default.
- W2004114486 isRetracted "false" @default.
- W2004114486 magId "2004114486" @default.